CAS 3115784-59-0

Fórmula: C24H26N4O2S

InChI: InChI=1S/C24H26N4O2S/c1-28(2)9-4-10-30-21-6-3-5-17(11-21)14-25-24(29)23-13-19-8-7-18(12-22(19)31-23)20-15-26-27-16-20/h3,5-8,11-13,15-16H,4,9-10,14H2,1-2H3,(H,25,29)(H,26,27)

Chave InChI: CEBZQGSTFMCVML-UHFFFAOYSA-N

SMILES: CN(C)CCCOC1=CC=CC(=C1)CNC(=O)C2=CC3=C(S2)C=C(C=C3)C4=CNN=C4

ROCK2-IN-14

CAS: 3115784-59-0

ROCK2-IN-14 is an orally bioavailable and selective ROCK2 inhibitor with an IC₅₀ of 4.8 nM, and it is 212 times more selective for ROCK2 over ROCK1 (IC₅₀=1.01 μM). By inhibiting the ROCK2/S100A9 signaling pathway, ROCK2-IN-14 reduces S100A9 expression, inhibits NM2 phosphorylation, and corrects cytoskeletal abnormalities. Consequently, it lowers levels of inflammatory cytokines, alleviates skin inflammation, and exhibits anti-inflammatory effects. In atopic dermatitis (AD) mouse models, ROCK2-IN-14 significantly reduces ear thickening and decreases IgE, TNF-α, IL-6, and TSLP levels. The compound demonstrates good safety, with a maximum tolerable oral dose exceeding 500 mg/kg, making it a potential candidate for atopic dermatitis research.

Fórmula: C₂₄H₂₆N₄O₂S

Peso molecular: 434.55

Ref: TM-T217783